We are live on ! Find out more
MDVL

MedAvail Holdings, Inc. Common Stock

Delisted

MDVL was delisted on the 12th of February, 2024.

7 hedge funds and large institutions have $505K invested in MedAvail Holdings, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

266% more capital invested

Capital invested by funds: $138K → $505K (+$367K)

40% more funds holding

Funds holding: 57 (+2)

0.69% more ownership

Funds ownership: 2.3%2.99% (+0.69%)

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

MDVL Hedge Fund Activity: Q1 2017 in Review

7 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q1 2017, worth a combined $505K — up 266% from $138K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new MDVL positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $125K. The largest seller was UBS Group, exiting entirely with an estimated $1.84K sold.

  • 7 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q1 2017, up from 5 in Q4 2016.
  • Funds reported $505K of MedAvail Holdings, Inc. Common Stock stock for Q1 2017, up 266% quarter-over-quarter.
  • 4 funds opened new MedAvail Holdings, Inc. Common Stock positions in Q1 2017 and 1 closed out, a net change of +3 holders.
  • The largest MedAvail Holdings, Inc. Common Stock buyer in Q1 2017 was Morgan Stanley, an estimated $125K added.
  • The largest MedAvail Holdings, Inc. Common Stock seller in Q1 2017 was UBS Group, an estimated $1.84K sold.

Based on aggregated 13F filings for Q1 2017.